Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Verrica Provides Business and Operational Update GlobeNewswire - Fri Dec 20, 6:00AM CST

VRCA : 0.6843 (+5.49%)
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Dec 9, 3:15PM CST

VRCA : 0.6843 (+5.49%)
Verrica Pharmaceuticals Announces NDA Submission for TO-208 for Molluscum Contagiosum Treatment in Japan Quiver Quantitative, Inc. - Fri Dec 6, 5:22PM CST

Verrica Pharmaceuticals announced Torii's NDA submission for TO-208 to treat molluscum contagiosum in Japan.Quiver AI SummaryVerrica Pharmaceuticals Inc. announced that its partner Torii Pharmaceutical...

VRCA : 0.6843 (+5.49%)
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan GlobeNewswire - Fri Dec 6, 7:00AM CST

VRCA : 0.6843 (+5.49%)
Verrica Announces Pricing of $42.0 Million Public Offering GlobeNewswire - Thu Nov 21, 6:30AM CST

VRCA : 0.6843 (+5.49%)
Verrica Pharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants Quiver Quantitative, Inc. - Thu Nov 21, 1:20AM CST

Verrica Pharmaceuticals plans an underwritten public offering of common stock and warrants, subject to market conditions.Quiver AI SummaryVerrica Pharmaceuticals Inc. announced its plans to conduct an...

VRCA : 0.6843 (+5.49%)
Verrica Announces Proposed Public Offering GlobeNewswire - Wed Nov 20, 3:05PM CST

VRCA : 0.6843 (+5.49%)
Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition GlobeNewswire - Mon Nov 4, 3:05PM CST

VRCA : 0.6843 (+5.49%)
Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference GlobeNewswire - Thu Oct 24, 6:00AM CDT

VRCA : 0.6843 (+5.49%)
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday Motley Fool - Mon Jul 24, 2023

The company's shares dropped because it will require financing to help launch its first marketed product.

VRCA : 0.6843 (+5.49%)

Barchart Exclusives

4 Highest-Rated Dividend Aristocrats To Buy Now Barchart - Fri Dec 27, 6:00PM CST
These three highly-rated companies offer a combination of growth and at least 25 years of increasing dividends. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot